期刊文献+

HPLC同时测定抗疟复方制剂中磷酸咯萘啶、磺胺多辛与乙胺嘧啶含量 被引量:7

Simultaneous Determination of Malaridine,Sulfadoxine and Pyrimethamine in an Antimalarial Compound Preparation by HPLC
下载PDF
导出
摘要 目的 建立同时测定复方抗疟制剂中磷酸咯萘啶、磺胺多辛与乙胺嘧啶的高效液相色谱法.方法 醋酸-醋酸钠(pH6)-乙醇(30:70)为提取溶剂,ZORBAX RX-C18柱(4.6 mm×150mm,5 μm),[0.022 mol·L^-1盐酸-0.22%三乙胺水溶液(pH 2.3)]-乙腈(75:25)为流动相,流速1 mL·min^-1,非那西丁为内标,266 nm为检测波长.结果 非那西丁、磷酸咯萘啶、乙胺嘧啶与磺胺多辛的保留时间分别为:10.19,1.27,5.70和7.63 min.磷酸咯萘啶、乙胺嘧啶与磺胺多辛的线性范围、相关系数分别为20~400(mg·L^-1),r=0.999 3;2.05~40.20mg·L^-1,r=0.999 9;20.01~800.40mg·L^-1,r=0.999 9.磷酸咯萘啶、乙胺嘧啶与磺胺多辛的提取回收率和RSD(n=3)分别为(97.62±1.09)%,3.68%;(98.34±1.94)%,1.97%及(99.77±2.16)%,2.17%.结论 本方法灵敏度、准确度均能满足含量测定的需要,提取和测定快速简单,可用于该复方制剂的质量控制. OBJECTIVE To develop a high performance liquid chtromatographic(HPLC) method to determine malaridine sulfadoxine and pyrimethamine simultaneously in an antimalarial compound preperation simultaneously. METHODS Buffer(HAc-NaAc, pH 6)-EtOH(70:30) was used as extraction solvent. The chromatographic analysis was carried out using ZORBAX RX- C18 column(4.6 mm×150mm,5 μm) and mobile phase consisting of buffer[0.022 mol·L^- 1 HCl-0.22% triethylamine, pH 2.3]-ACN (75:25) at a flow rate of 1 mL·min^-1. Phenacifine was used as internal standard and all components were quantified with detection wavelength at 266 ran.RESULTS The recoveries of malaridine, sulfadoxine and pyrimethamine were (97.62 ± 1.09) % with RSD = 3.68 %, (99.77 ± 2.16) % with RSD = 2.17 % and ( 98.34 ± 1.94)% with RSD = 1.97 % (n = 3), respectively. The linear range and regression equation of malaridine, sulfadoxine and pyrimethamine were over the range of 20± 400 mg·L^-1 with r = 0.999 3,2.05 ±40.20 mg·L^-1 with r =0.999 9 and 20.01 ± 800.40 mg·L^-1 with r = 0.999 9. The retention time for the internal standard phenacitine, malaridine, pyrimethamine and sulfadoxine were 10.19,1.27,5.70 and 7.63 rain, respectirely. CONCLUSION The method, which is simple, sensitive and precise in the determination and extraction of those three components, can meet the requirements for the quality control of the antimalarial compound preparation.
出处 《中国药学杂志》 CAS CSCD 北大核心 2006年第8期634-636,639,共4页 Chinese Pharmaceutical Journal
基金 国家"九五"科技攻关课题(96-906-04-07)
关键词 高效液相色谱法 磷酸咯萘啶 磺胺多辛 乙胺嘧啶 非那西丁 HPLC malaridine sulfadoxine phosphate pyrimethamine phenacitine
  • 相关文献

参考文献6

  • 1SHAO B R,YE X Y.Delay in emergence of resistance to pyronaridine phosphate in plasmodiumberghei[J].Acta Pharmacol Sin,1986,7(5):463-467.
  • 2黄在松,邵葆若,蒙锋,施晓华.海南省吊罗山地区恶性疟原虫对咯萘啶、磺胺多辛、乙胺嘧啶联用敏感性的5年监测[J].中国寄生虫病防治杂志,1993,6(2):81-83. 被引量:1
  • 3LIUXR WURJ.HPLC Simultaneous determination of pyronaridine and primaquind in plasma[J].中国药科大学学报,1989,20(4):240-242.
  • 4BABALOLA C P,SCRIBA G K,SOWUNMI A,et al.Alawode OA:Liquid chromatographic determination of pyronaridine in human plasma and oral dosage form[J].J Chromatogr B Analyt Technol Biomed Life Sci,2003,795(2):265-272.
  • 5WAGES S A,PATCHEN L C,CHURCHILL F C.Analysis of blood and urine samples from macaca mulata for pyronaridine by high-performance liquid chromatography with electrochemical detection[J].J Chromatogr,1990,527(1):115-126.
  • 6SALEH M I,LOH H K.Liquid chromatographic assay of pyronaridine in plasma and blood[J].Anal Chem Acta,1993,282:559-564.

同被引文献2138

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部